These innovative therapies, including Rybelsus, belong to a class of drugs called GLP-1 receptor agonists . Originally developed for managing high blood sugar, they work by assisting the organism to release more insulin and curbing excessive glucose levels. Furthermore , their potential to encourage weight loss has resulted to significant attention